MENU
+Compare
CVM
Stock ticker: ASE
AS OF
Jan 30 closing price
Price
$0.40
Change
+$0.01 (+2.56%)
Capitalization
28.56M

CVM Cel-Sci Corp Forecast, Technical & Fundamental Analysis

a provider of immunotherapy products for the treatment of cancer and infectious diseases

Industry Biotechnology
CVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CVM with price predictions
Jan 29, 2025

CVM's RSI Indicator ascends from oversold territory

The RSI Indicator for CVM moved out of oversold territory on January 10, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 29 similar instances when the indicator left oversold territory. In of the 29 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CVM just turned positive on January 22, 2025. Looking at past instances where CVM's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CVM advanced for three days, in of 246 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 59 cases where CVM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on January 29, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CVM as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CVM broke above its upper Bollinger Band on January 27, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CVM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.301) is normal, around the industry mean (15.749). P/E Ratio (0.000) is within average values for comparable stocks, (88.784). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.848). CVM has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (276.027).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CVM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
CVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CVM is expected to report earnings to fall 28.57% to -10 cents per share on December 31

Cel-Sci Corp CVM Stock Earnings Reports
Q3'24
Est.
$-0.10
Q2'24
Missed
by $0.02
Q1'24
Missed
by $0.01
Q4'23
Est.
$-0.14
Q3'23
Beat
by $0.35
The last earnings report on August 15 showed earnings per share of -14 cents, missing the estimate of -11 cents. With 213.76K shares outstanding, the current market capitalization sits at 28.56M.
A.I. Advisor
published General Information

General Information

a provider of immunotherapy products for the treatment of cancer and infectious diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
8229 Boone Boulevard
Phone
+1 703 506-9460
Employees
44
Web
https://www.cel-sci.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INSE10.020.35
+3.62%
Inspired Entertainment
QNTM3.020.08
+2.72%
Quantum Biopharma Ltd
BCE23.900.20
+0.84%
BCE
LQDT37.300.27
+0.73%
Liquidity Services
LNTH92.790.26
+0.28%
Lantheus Holdings

CVM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CVM has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CVM jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVM
1D Price
Change %
CVM100%
+3.66%
MDGL - CVM
43%
Loosely correlated
+3.66%
CYTK - CVM
40%
Loosely correlated
+2.71%
ADXN - CVM
39%
Loosely correlated
-3.31%
EYPT - CVM
38%
Loosely correlated
+4.14%
ABP - CVM
32%
Poorly correlated
-8.04%
More